MediciNova, Inc. (MNOV) Social Stream



MediciNova, Inc. (MNOV): $2.27

0.02 (+0.89%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MNOV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 455

in industry

Featured Post From StockTwits About MNOV

$MNOV

$MNOV


10-Q key features

Pursue the development of MN-166 (ibudilast) with NON-DILUTIVE financings.

Pursue the development of MN-001 (tipelukast) for fibrotic and other diseases.

Consider strategic partnerships with one or more leading pharmaceutical.

Blackrock, vanguard and JPM increased their position significantly. JPM today by 222% more.

something cooking? Guess, time will say. Follow for more update

https://twitter.com/pratiks77932094/status/1423476666882461701?s=21
Sharmaji27, published August 12, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4136 seconds.